All 2 tracked stories fall under one category: industry. Of the tracked stories, 1 of 2 also mention BTIG Research, the most common co-covered peer. That works out to roughly 0.1 stories per week across a 113-day span. The 5 average consequence score is below the beat benchmark of 5.4 in the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Wall Street Zen
All 2 tracked stories fall under one category: industry. Of the tracked stories, 1 of 2 also mention BTIG Research, the most common co-covered peer. That works out to roughly 0.1 stories per week across a 113-day span. The 5 average consequence score is below the beat benchmark of 5.4 in the same window. Each story carries 2.5 original sources on average, compared with 2.8 for the broader beat in this window. Wall Street Zen appears in 2 tracked EdTech stories published from March 8, 2026 through June 28, 2026.
Stories tracked
2
Per week
0.1
Sources per story
2.5
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 134 EdTech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Wall Street Zen. Shared-story counts are live from our verified record — not editorial picks.
Wall Street analyst BTIG reaffirmed a buy rating and $19 target for McGraw Hill (MH), projecting a 107.63% gain from its depressed $9.15 share price. The call highlights deep value in the educational publisher as the entire edtech sector undergoes a post-pandemic correction. With a consensus 'Moderate Buy' and $18.72 target, the stock's extreme undervaluation could reward contrarian edtech investors.
Wall Street Zen has upgraded Docebo (DCBO) to a Strong-Buy rating, signaling robust confidence in the corporate learning management system (LMS) provider. This move comes alongside broader market upgrades for Organogenesis and Weatherford International, reflecting a positive shift in analyst sentiment toward high-growth specialized sectors.
